Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_assertion type Assertion NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_head.
- NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_assertion wasGeneratedBy ECO_0000218 NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_provenance.
- NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_assertion wasDerivedFrom ctd_human-20150221 NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_provenance.
- NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_assertion SIO_000772 17043644 NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_provenance.
- NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_assertion evidence source_evidence_curated NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_provenance.
- NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_assertion description "[Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP25026.RA5J-IuYoTCbZg7aaEeOYYWfkDDPR3TBjhwVaMY-I_qF0130_provenance.